yyEfficacy of immune-checkpoint inhibitor (ICI) combination as a first-line (1L) therapy in metastatic renal cell carcinoma (mRCC) with sarcomatoid histology: A systematic review and meta-analysis. Meeting Abstract (Web of Science)

International Collaboration

cited authors

  • Siddiqi, Rabbia; Kumar, Gaurav; Ijaz, Hafsah; Naqvi, Syed Arsalan Ahmed; Ayaz, Ahsan; Bin Riaz, Zaryab; Bryce, Alan Haruo; Ho, Thai Huu; Bin Riaz, Irbaz; Singh, Parminder

publication date

  • February 20, 2023


published in



  • 41